Therapy of Alzheimer's Disease with an antibody against oligomeric pyro-Glu-Abeta peptides

Scientists at the University of Gottingen developed a novel, proprietary antibody for the therapy and/or diagnosis of Alzheimer's Disease through the targeting of specifically pyro-Glu-Amyloid beta peptides.

http://www.innovations-report.com/html/reports/technology_offerings/therapy_alzheimer_s_disease_antibody_oligomeric_pyro_212524.html